Carnegie has published a new commissioned research report initiating coverage on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.6 SEK | +3.88% | +7.20% | +60.48% |
May. 15 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 | |
May. 14 | EQL Pharma AB Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Carnegie has published a new commissioned research report initiating coverage on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+60.48% | 150M | |
-35.29% | 10.84B | |
-8.96% | 7.78B | |
+4.90% | 6.14B | |
-14.10% | 5.9B | |
+74.92% | 4.79B | |
-4.09% | 4.55B | |
-7.88% | 3.77B | |
-22.05% | 3.1B | |
-13.61% | 2.81B |